Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nanoparticles for immune system targeting.

Juan Du1, Yu Shrike Zhang2, Divia Hobson3

  • 1Centre for Translational Microbiome Research (CTMR), Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17177 Stockholm, Sweden.

Drug Discovery Today
|April 9, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomaterials based strategies for rotator cuff repair.

Colloids and surfaces. B, Biointerfaces·2017
Same author

In-plane microvortices micromixer-based AC electrothermal for testing drug induced death of tumor cells.

Biomicrofluidics·2016
Same author

Neuroprotective effects of oxysophocarpine on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusion.

Pharmaceutical biology·2014
Same author

Intertriginous cutaneous mastocytosis in a 16-year-old boy.

International journal of dermatology·2014
Same author

Lycium barbarum polysaccharide prevents focal cerebral ischemic injury by inhibiting neuronal apoptosis in mice.

PloS one·2014
Same author

Clinical analysis on 33 patients with hypothalamic syndrome in Chinese children.

Journal of pediatric endocrinology & metabolism : JPEM·2014
Same journal

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Drug discovery today·2026
Same journal

Organoid-AI platforms need integrated governance in drug discovery.

Drug discovery today·2026
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
See all related articles

Nanoparticles (NPs) are engineered to modulate the immune system for drug delivery and therapeutics. Recent advancements focus on targeting specific immune pathways for enhanced therapies.

Area of Science:

  • Immunology
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Nanoparticles (NPs) are integral to various applications targeting the immune system.
  • They function as drug delivery vehicles, vaccine adjuvants, and therapeutic agents for diverse diseases.
  • NPs offer precise targeting capabilities within the immune system.

Purpose of the Study:

  • To provide an update on recent progress in nanoparticle-based immune modulation.
  • To highlight advancements in engineering NPs for targeted immune therapies.
  • To review the integration of NPs with immune-targeting moieties.

Main Methods:

  • Review of recent scientific literature and research findings.
  • Analysis of nanoparticle engineering strategies for immune targeting.

Related Experiment Videos

  • Synthesis of information on therapeutic applications and vaccine adjuvant roles.

    • Main Results:

    • Nanoparticles demonstrate significant potential in modulating immune responses.
    • Engineered NPs can specifically target distinct cellular components of the immune system.
    • The combination of NPs with targeting moieties enhances the efficacy of immune therapies.

    Conclusions:

    • Nanoparticle technology is crucial for developing advanced immunotherapies.
    • Targeted delivery systems using NPs offer improved therapeutic outcomes.
    • Continued research in this field promises novel treatments for various diseases.